Sort by
Refine Your Search
-
Listed
-
Category
-
Field
-
complex biology research experiments. As a successful candidate, you will: Characterize engineered natural killer (NK) cells and patient samples. Possess pathology knowledge and proficiency in various
-
technology and contribute to groundbreaking discoveries in cancer and related diseases. For more information on Dr. Saul Priceman’s research, please visit here . As a successful candidate, you will: Conduct
-
specific to the RefleXion linear accelerator. RefleXion is a novel radiation machine that delivers treatment using positron emission tomography (PET) guidance. As it is a new technology and our program is
-
edge technology, research and clinical immunotherapeutic programs. New personnel will be trained in project specific techniques and procedures. As a successful candidate, you will: · Manufacture
-
, shaping the future of medicine through cutting-edge research. The Department of Integrative Translational Sciences at City of Hope comprises a diverse team of biologists, data scientists, engineers
-
clinical setting Your qualifications should include: · Ph.D. degree chemistry, biochemistry, structural biology, biophysics or a related discipline is required. · Knowledge of protein engineering
-
edge technology, research and clinical immunotherapeutic programs. New personnel will be trained in project specific techniques and procedures. As a successful candidate, you will: · Manufacture
-
-paced lab involved in cutting edge technology, research and clinical immunotherapeutic programs. New personnel will be trained in project specific techniques and procedures. As a successful candidate
-
clinical trials, including first-in-human studies with genetically engineered hematopoietic stem and progenitor cells (HSPC) and T cells. As a successful candidate, you will: · Conduct research
-
. Human synthetic insulin, monoclonal antibodies and numerous breakthrough cancer drugs are based on technology developed at the institution. AccessHope™, a subsidiary launched in 2019 serves employers and